ReportsWeb- Burns Global Clinical Trials Review H1 2017 | Page 2

Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001858616/sample Table of Content: List of Tables 4 List of Figures 5 Report Guidance 6 Publisher Clinical Trials Report Coverage 7 Clinical Trials by Region 8 Clinical Trials and Average Enrollment by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by G7 Countries: Proportion of Burns to Dermatology Clinical Trials 16 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Burns to Dermatology Clinical Trials 19 Clinical Trials by Phase in E7 Countries 20 Clinical Trials in E7 Countries by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Clinical Trials by End Point Status 25 Subjects Recruited Over a Period of Time 26 Clinical Trials by Sponsor Type 27 Prominent Sponsors 28